<DOC>
	<DOCNO>NCT02022579</DOCNO>
	<brief_summary>A type magnetic resonance imaging call diffusion weight imaging ( DWI ) test define cancerous non-cancerous lesion breast .</brief_summary>
	<brief_title>DCE-MRI DWI Detection Diagnosis Breast Cancer</brief_title>
	<detailed_description>For study , investigator plan evaluate DWI scan perform woman breast lesion identify conventional breast MRI . The investigator determine whether ADC threshold define distinguish benign malignant lesion DWI , ass difference ADC cutoff mass non-mass lesion , investigate potential improvement accuracy use technique nonzero minimum b-value ( remove perfusion effect ADC measure ) normalize ADC measure ( account variation water content factor ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Willing able provide write informed consent ; 18 year age older ; Successful completion breast MR examination DWI require protocol ; Undiagnosed breast lesion ( BIRADS 3 , 4 , 5 ) identify MRI . The BIRADS assessment must refer focal finding within breast ( i.e . mass , nonmass , focus ) oppose diffuse process ( e.g . background parenchymal enhancement , skin thicken ) lesion outside subcutaneous breast ( e.g . axillary lymph node , focal skin lesion , osseous lesion , etc. ) . Participants current recent history ( within 6 month prior MRI ) chemotherapy cancer ; Neoadjuvant chemotherapy MRI confirmation lesion outcome ( study lesion must biopsied prior undergoing chemotherapy ) ; Pregnant ( female childbearing potential define premenopausal female capable become pregnant confirmation pregnancy status per site 's standard practice do prior MRI ) ; Unwilling suitable undergo MRI use contrast agent gadolinium .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Diagnosis</keyword>
	<keyword>Malignant</keyword>
	<keyword>Benign</keyword>
	<keyword>Biopsy</keyword>
</DOC>